Sunesis Pharmaceuticals, Inc. Announces Clinical Trial Updates and 2013 Milestones at the 31st Annual JP Morgan Healthcare Conference
Published: Jan 11, 2013
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, provided a corporate update, including a clinical trial enrollment update and overview of 2013 major corporate milestones, in a presentation at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco. A webcast replay of the presentation, which was delivered today, January 10, at 12:00 PM Pacific Time, is archived on the Sunesis website at http://ir.sunesis.com and will be available for two weeks.